March 28 (Reuters) - Alkem Laboratories Ltd:
* GOT A FORM 483 WITH 13 OBSERVATIONS AFTER US FDA INSPECTION AT CO’S MANUFACTURING FACILITY AT AMALIYA, DAMAN
* SAYS US FDA HAD CONDUCTED INSPECTION AT THE FACILITY FROM MARCH 19-27
* SHALL PUT TOGETHER DETAILED RESPONSE WITH ADEQUATE CORRECTIVE AND PREVENTIVE MEASURES TO ADDRESS US FDA OBSERVATIONS
* IN RESPONSE TO FORM 483 BY FDA AT CO'S ST LOUIS FACILITY, CO HAS SUBMITTED CORRECTIVE AND PREVENTIVE ACTION PLAN Source text: bit.ly/2I9G2xd Further company coverage:
